✦ LIBER ✦

Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine

✍ Scribed by KAZUO YAMADA; SHIGENOBU KANBA; WANG ZU-CHENG; EIJI SUZUKI; FANG YI-YU; YAN HE-GIN; MASASHI NIBUYA; GOHEI YAGI; MASAHIRO ASAI

Book ID: 115173760
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 400 KB
Volume: 50
Category: Article
ISSN: 1323-1316
DOI: 10.1111/j.1440-1819.1996.tb00566.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The relationship between the plasma conc

The relationship between the plasma concentration of blonanserin, and its plasma anti-serotonin 5-HT2A activity/anti-dopamine D2 activity ratio and drug-induced extrapyramidal symptoms

✍ Hidenobu Suzuki; Keishi Gen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

The relationship between the daily dose,

The relationship between the daily dose, the plasma concentration of blonanserin, and its plasma anti-dopamine D2 and anti-serotonin 5-HT2A activity

✍ Hidenobu Suzuki; Keishi Gen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Objective Blonanserin (BNS) possesses anti-serotonin 5-HT 2A activity in addition to anti-dopamine D 2 activity, which is characteristic of second-generation antipsychotics, little information is available on its pharmacologic profile in vivo. We investigated the BNS daily dose, plasma concentration

Plasma homovanillic acid, plasma anti-D1

Plasma homovanillic acid, plasma anti-D1 and -D2 dopamine-receptor activity, and negative symptoms in chronically medicated schizophrenia

✍ Eiji Suzuki; Shigenobu Kanba; Masashi Nibuya; Hiroki Koshikawa; Toshio Nakai; Go 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 724 KB

Time course of central nervous dopamine-

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel®) in patients with schizophrenia

✍ O. Gefvert; M. Bergström; B. Långström; T. Lundberg; L. Lindström; R. Yates 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 355 KB

F15063, a potential antipsychotic with d

F15063, a potential antipsychotic with dopamine D2/D3antagonist, 5-HT1Aagonist and D4partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

✍ Marie-Bernadette Assié; Laurent Bardin; Agnès Auclair; Nathalie Consul-Denjean; 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 227 KB

P.3.d.007 F15063, a novel antipsychotic

P.3.d.007 F15063, a novel antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: III. Duration of brain D2-like receptor occupancy, antipsychotic-like activity and plasma concentration in rodents

✍ M.B. Assié; L. Bardin; A.L. Auclair; N. Consul-Denjean; F. Sautel; M.S. Kleven; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB